Effect of age on the efficacy and safety of Panax notoginseng saponins in acute ischemic stroke: a prespecified secondary analysis of the PANDA study

Zhou B, Zhang J, Zhao Y, Li X, Anderson CS, Xie B, et al. Caregiver-delivered stroke rehabilitation in rural China. Stroke. 2019;50:1825–30.

Article  PubMed  Google Scholar 

Ke L, Mao W, Shao F, Zhou J, Xu M, Chen T, et al. Association between pretreatment lymphocyte count and efficacy of immune-enhancing therapy in acute necrotising pancreatitis: a post-hoc analysis of the multicentre, randomised, placebo-controlled TRACE trial. eClinicalMedicine. 2023;58:101915.

Article  PubMed  PubMed Central  Google Scholar 

Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–57.

Article  CAS  PubMed  Google Scholar 

Rojas JI, Zurrú MC, Romano M, Patrucco L, Cristiano E. Acute ischemic stroke and transient ischemic attack in the very old–risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol. 2007;14:895–9.

Article  CAS  PubMed  Google Scholar 

Winovich DT, Longstreth WT, Arnold AM, Varadhan R, Zeki Al Hazzouri A, Cushman M, et al. Factors associated with ischemic stroke survival and recovery in older adults. Stroke. 2017;48:1818–26.

Article  PubMed  PubMed Central  Google Scholar 

Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–7.

Article  CAS  PubMed  Google Scholar 

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344-418.

Article  PubMed  Google Scholar 

Pilotto A, Brass C, Fassbender K, Merzou F, Morotti A, Kämpfer N, et al. Premorbid frailty predicts short- and long-term outcomes of reperfusion treatment in acute stroke. J Neurol. 2022;269:3338–42.

Article  PubMed  Google Scholar 

Zhang Q, Wang A, Xu Q, Xia X, Tian X, Zhang Y, et al. Efficacy and safety of ginkgo diterpene lactone meglumine in acute ischemic stroke: a randomized clinical trial. JAMA Netw Open. 2023;6: e2328828.

Article  PubMed  PubMed Central  Google Scholar 

Wang A, Jia B, Zhang X, Huo X, Chen J, Gui L, et al. Efficacy and safety of butylphthalide in patients with acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2023;80:851.

Article  PubMed  PubMed Central  Google Scholar 

Shimada Y, Nagahara A, Hojo M, Asaoka D, Sasaki H, Ueyama H, et al. Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users. Gastroenterol Res Pract. 2015;2015: 252963.

Article  PubMed  PubMed Central  Google Scholar 

Wang QH, Kuang N, Hu WY, Yin D, Wei YY, Hu TJ. The effect of Panax notoginseng saponins on oxidative stress induced by PCV2 infection in immune cells: in vitro and in vivo studies. J Vet Sci. 2020;21: e61.

Article  PubMed  PubMed Central  Google Scholar 

Yang X, Xiong X, Wang H, Wang J. Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies. Evid Based Complement Alternat Med. 2014;2014: 204840.

Article  PubMed  PubMed Central  Google Scholar 

Zhu B, Zhang W, Lu Y, Hu S, Gao R, Sun Z, et al. Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury. Biomed Pharmacother. 2018;105:159–66.

Article  CAS  PubMed  Google Scholar 

Zhou D, Cen K, Liu W, Liu F, Liu R, Sun Y, et al. Xuesaitong exerts long-term neuroprotection for stroke recovery by inhibiting the ROCKII pathway, in vitro and in vivo. J Ethnopharmacol. 2021;272: 113943.

Article  CAS  PubMed  Google Scholar 

Li F, Zhao H, Han Z, Wang R, Tao Z, Fan Z, et al. Xuesaitong may protect against ischemic stroke by modulating microglial phenotypes and inhibiting neuronal cell apoptosis via the STAT3 signaling pathway. CNS Neurol Disord Drug Targets. 2019;18:115–23.

Article  CAS  PubMed  Google Scholar 

Cai B-X, Li X-Y, Chen J-H, Tang Y-B, Wang G-L, Zhou J-G, et al. Ginsenoside-Rd, a new voltage-independent Ca2+ entry blocker, reverses basilar hypertrophic remodeling in stroke-prone renovascular hypertensive rats. Eur J Pharmacol. 2009;606:142–9.

Article  CAS  PubMed  Google Scholar 

Hui Z, Sha D-J, Wang S-L, Li C-S, Qian J, Wang J-Q, et al. Panaxatriol saponins promotes angiogenesis and enhances cerebral perfusion after ischemic stroke in rats. BMC Complement Altern Med. 2017;17:70.

Article  PubMed  PubMed Central  Google Scholar 

Zhu T, Meng X-B, Dong D-X, Zhao L-Y, Qu M-W, Sun G-B, et al. Xuesaitong injection (lyophilized) combined with aspirin and clopidogrel protect against focal cerebral ischemic/reperfusion injury in rats by suppressing oxidative stress and inflammation and regulating the NOX2/IL-6/STAT3 pathway. Ann Palliat Med. 2021;10:1650–67.

Article  PubMed  Google Scholar 

Zhang J-S, Zhang B-X, Du M-M, Wang X-Y, Li W. Chinese preparation Xuesaitong promotes the mobilization of bone marrow mesenchymal stem cells in rats with cerebral infarction. Neural Regen Res. 2016;11:292–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu L, Song H, Zhang C, Wang A, Zhang B, Xiong C, et al. Efficacy and safety of Panax notoginseng saponins in the treatment of adults with ischemic stroke in china: a randomized clinical trial. JAMA Netw Open. 2023;6: e2317574.

Article  PubMed  PubMed Central  Google Scholar 

Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–53.

Article  PubMed  Google Scholar 

Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, et al. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet. 2020;395:1374–81.

Article  CAS  PubMed  Google Scholar 

Pan Y, Wu T-T, Hou X-G, Yang Y, Deng C-J, Wang S, et al. Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial. Platelets. 2023;34:2206915.

Article  PubMed  Google Scholar 

Lindley RI. Drug trials for older people. J Gerontol A Biol Sci Med Sci. 2012;67:152–7.

Article  PubMed  Google Scholar 

Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–95.

Article  PubMed  Google Scholar 

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997;349:1641–9.

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349:1569–81.

Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W, Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke. 2004;35:528–32.

Article  CAS  PubMed  Google Scholar 

Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol. 2002;90:625–8.

Article  PubMed  Google Scholar 

Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation. 2001;103:363–8.

Article  CAS  PubMed  Google Scholar 

Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56:919–33.

Article  CAS  PubMed 

Comments (0)

No login
gif